Middle East Pharmaceutical Industries Company (TADAWUL:4016)

Saudi Arabia · Delayed Price · Currency is SAR

99.50

+1.80 (1.84%)

Mar 3, 2026, 3:14 PM AST

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Private Customers	268.29M	245.32M	207.97M	-	-
Private Customers Growth	9.37%	17.96%	-	-	-
Public Customers	75.68M	55.91M	68.58M	-	-
Public Customers Growth	35.37%	-18.48%	-	-	-
Export Customers	50.03M	37.22M	26.11M	-	-
Export Customers Growth	34.42%	42.54%	-	-	-
Medicines	-	-	-	157.70M	113.51M
Medicines Growth	-	-	-	38.94%	-
Cosmetics	-	-	-	129.52M	188.15M
Cosmetics Growth	-	-	-	-31.16%	-
Total	394.00M	338.44M	302.66M	287.22M	301.66M
Total Growth	16.42%	11.82%	5.38%	-4.79%	-

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Kingdom of Saudi Arabia	343.97M	301.22M	276.55M	259.78M	279.08M
Kingdom of Saudi Arabia Growth	14.19%	8.92%	6.46%	-6.91%	-
Kuwait	10.94M	9.35M	-	-	-
Kuwait Growth	17.03%	-	-	-	-
United Arab Emirates	18.06M	12.93M	-	-	-
United Arab Emirates Growth	39.61%	-	-	-	-
Other Export	-	-	26.11M	27.44M	22.58M
Other Export Growth	-	-	-4.85%	21.52%	-
Other Countries	21.03M	14.94M	-	-	-
Other Countries Growth	40.80%	-	-	-	-
Total	394.00M	338.44M	302.66M	287.22M	301.66M
Total Growth	16.42%	11.82%	5.38%	-4.79%	-

Source: S&P Global Market Intelligence.